Coupling HA Molecules from Various Flu Strains Could Make Vaccines More Effective

Results from a recent study suggest coupling HA molecules from various flu strains could make flu vaccines more effective.

FDA Approves Chikungunya Vaccine

The U.S. Food and Drug Administration (FDA) has approved VIMKUNYA (chikungunya vaccine, recombinant) for injection, the first virus-like particle (VLP) single-dose chikungunya vaccine in the U.S. for persons 12 years of age and older. 

Update on Rabies

Though mostly eradicated in the U.S., treatment for rabies must begin immediately with hyperimmune globulin and vaccines.

GSK’s Penmenvy Meningococcal Vaccine Approved by FDA

GSK’s Penmenvy (meningococcal groups A, B, C, W and Y vaccine) has been approved by the U.S. Food and Drug Administration for use in individuals aged 10 through 25 years.

RSV Vaccine Prompts Robust Response in Older Recipients

Findings of a Phase III randomized controlled trial showed Pfizer’s RSV Prefusion F (RSVpreF) vaccine triggered strong immune responses among people aged 60 years and older during its first two seasons.

Grant Awarded to Accelerate Pandemic Influenza mRNA Vaccine Development

The U.S. Department of Health andHuman Services will provide approximately $590 million to Moderna to accelerate the development of mRNAbased pandemic influenza vaccines and enhance mRNA platform capabilities

New Personalized Vaccine May Treat Pancreatic Cancer

A new study published in the journal Nature found that a personalized vaccine, named autogene cevumeran, is showing promising results for treating pancreatic cancer, one of the deadliest malignancies.

Vaccine Shows Promise In Stopping Plaque Buildup in Arteries

Chinese researchers have developed a “cocktail” nanovaccine to prevent plaque from building up in the arteries, an underlying factor in heart disease, which is the leading cause of death worldwide.

HIV Vaccine Elicits Potent Response in Nonhuman Primates

A study conducted by researchers at Weill Cornell Medicine has demonstrated that a series of six vaccinations containing a modified protein from the surface of HIV particles stimulated initial steps of a potent immune response in young nonhuman primates.

First Nasal Self-Administered Flu Vaccine Approved by FDA

FluMist, the first influenza nasal spray vaccine that can be self-administered, has been approved by the U.S. Food and Drug Administration (FDA).